“We are seeing more people with covid, especially mild covid, but I would not call it a surge,” said Shira I. Doron, chief of infection control at Tufts Health and hospital epidemiologist at Tufts Medical Center in Boston.
Hotez recommends that people of all ages get the shot. “All the covid numbers are climbing, and it is a big unknown: Is this going to turn into a significant wave as we progress into the fall or not?” he said.That’s similar to the FDA position, which argues the coronavirus vaccine should be treated like the flu shot, with an updated product recommended yearly for everyone 6 months and older.
The newly formulated vaccine is a monovalent, with a single component designed to target an omicron variant called XBB.1.5. Previous boosters, which were bivalents, aimed to counter the original coronavirus strain and the BA.4 and BA.5 variants — all long gone.in the United States, but it is closely related to the other XBB variants making up most cases now. That includes
BA.2.86 “appears to be a nothingburger,” said John P. Moore, professor of microbiology and immunology at Weill Cornell Medicine. “It has been showing a very slow rate of increase, not an explosive event. If it were going to have a huge impact, we would know it by now.”that “early research data from multiple labs are reassuring and show that existing antibodies work against the new BA.2.86 variant.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: sdut - 🏆 5. / 95 Read more »
Source: chicagotribune - 🏆 8. / 91 Read more »